French National Assembly okays 'right to die' law
May 27 (UPI) -- France's National Assembly approved a measure that would legalize assisted suicide and euthanasia if signed into law.
The French lawmakers passed the measure, dubbed the "right to die" law, on a 305-199 vote during the measure's first reading in the National Assembly, but the conditions would be among the most restrictive in Europe, The Guardian reported.
The measure authorizes assisted suicide or euthanasia for adults ages 18 and over under very strict conditions.
A patient must have a "serious and incurable" illness that has become either terminal or "advanced" to qualify for the procedure, Politico reported.
They also must experience "unbearable" psychological or physical suffering that resists treatment.
Patients must be able to provide informed consent and must self-administer any lethal medication if they are physically capable of doing so.
A medical doctor also must approve the procedure for respective patients if the proposed measure becomes law.
Centrist and leftwing lawmakers generally voted in favor of the measure, while conservative lawmakers mostly opposed it.
Although the National Assembly passed the bill, it faces a vote in the Senate and goes back to the National Assembly for an additional vote following a second reading.
France recently implemented a new parliamentary system that requires the National Assembly to vote on bills during a first reading and then again during a second reading upon passage in the Senate.
Several other European states, including Austria, Belgium, Spain and Switzerland, have similar laws in effect.
Lawmakers in the United Kingdom are considering legalizing a similar procedure there.
If French lawmakers do not legalize the right to die, French President Emmanuel Macron has said it could be put on a ballot for a public vote.
The National Assembly also approved a measure that would legalize palliative care that relieves symptoms of serious illnesses and medical conditions to improve respective patients' quality of life.
That measure received unanimous support in the National Assembly and was sent to the French Senate for consideration.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Hill
24 minutes ago
- The Hill
Trump doesn't have to quit UNESCO again because we never lawfully rejoined
President Trump recently announced that the United States was quitting the United Nations Economic, Social, and Cultural Organization (UNESCO) for the third time. This is good news – UNESCO has championed gender ideology in education, discriminatory DEI policies, and the entire litany of woke doctrines. It has also worked to erase Jewish history in the Holy Land. But the administration did not need to bother with formally withdrawing from the treaty — from a constitutional perspective, the U.S. hasn't been a member at least since Trump first quit it in 2017. When Biden sought to rejoin the Paris-based agency in 2023, he neglected to seek authorization from Congress. No one made a big deal of it then, but it means that, for domestic law purposes, the U.S. never actually rejoined. This is an important point with implications for numerous international organizations, especially as the administration sets out on an agenda of U.N. reform. Membership in international organizations was not supposed to be a political revolving door. Congress authorizes membership at the outset. After the U.S. leaves, a whole new congressional authorization must be obtained by any president wishing to rejoin. Under the Constitution, the president can only bring the country into a treaty with the 'consent' of two-thirds of the Senate. That is a substantial hurdle, and deliberately so: Commitments to foreign countries can be harder to pull out of than domestic ones. They can become a way of imposing obligations on the country that are then out of reach of the democratic process. In the 20th century, presidents have often relied on the approval of a majority of both Houses instead, a dubious practice but now widely followed. When the U.S. first joined UNESCO in 1946 (and the World Health Organization in 1948), President Truman was acting pursuant a law passed by both Houses authorizing him to do so. But Congress did not reauthorize Biden's reentry to UNESCO. Instead, he treated the 1946 authorization as a lifetime membership, when in fact it was only a one-time pass. If the U.S. quit a treaty that the Senate had ratified — say the NATO treaty — then a decision to rejoin would be subject to a new requirement of advice and consent. Congressional authorization is a stand-in for Senate ratification and should be subject to the same rules. Consider a parallel case: If a president fires a senate-confirmed appointee, and he or a subsequent president wishes to return him to the same post, no one would argue that he could do so simply on the grounds that the Senate had previously confirmed him. Indeed, Andrew Jackson's Attorney General resigned from his position, and was then reappointed to it — only to be rejected by the Senate. As a statutory matter, the 1946 agreement on UNESCO allowed the president to 'accept membership' — not accept, and accept, and accept again. If a congressional authorization is good for infinite rounds of quitting and rejoining, it makes getting out of international agreements harder than getting in – exactly the opposite of what the Framers intended. The argument of perpetual authorization was invented by Jimmy Carter, who purported to rejoin the International Labor Organization in 1980 based on a 1934 authorization. President Bush neglected to seek congressional approval when he rejoined UNESCO in 2002, nearly two decades after Reagan quit. Neither instance attracted much attention, and two modern actions do not prove a constitutional rule. There is a good argument for the Trump administration having withdrawn from UNESCO as if it were a member — to avoid any doubt or subsequent quibbling. But the administration should clarify that it is 'quitting' only out of an excess of caution, and does not see the U.S. as properly joined, which is consistent with its nonpayment of any dues. To avoid abuse by future administrations, Congress should repeal the antiquated authorizations for UNESCO and WHO, which Trump also announced withdrawal from. If a subsequent president wants to rejoin, he should have to sell it to Congress on the organization's existing records, not the hopes and dreams of the 1940s.
Business Wire
24 minutes ago
- Business Wire
Enanta Pharmaceuticals Files Patent Infringement Suit Against Pfizer in the Unified Patent Court of the European Union
WATERTOWN, Mass.--(BUSINESS WIRE)-- Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating novel, small molecule drugs for viral infections and immunological diseases, announced today that it has filed suit in the Unified Patent Court (UPC) of the European Union against Pfizer Inc. and certain of its subsidiaries (action number 35071/2025), seeking a determination of liability for use and infringement of European Patent No. EP 4 051 265 (the '265 Patent) in the manufacture, use and sale of Pfizer's COVID-19 antiviral, Paxlovid™ (nirmatrelvir tablets; ritonavir tablets). This enforcement action targets Pfizer's activities in the 18 countries of the European Union that are presently participating in the UPC. The European Patent Office's recent grant of the '265 Patent to Enanta was published in the European Patent Bulletin today. The '265 Patent is based on Enanta's July 2020 patent application describing coronavirus protease inhibitors invented by Enanta scientists. The '265 Patent is the European counterpart of U.S. Patent No. 11,358,953 (the '953 Patent) involved in ongoing U.S. litigation between Enanta and Pfizer Inc. Under UPC procedures, a hearing on the infringement action is expected to occur within the UPC's published 12-month target, with the decision rendered within weeks thereafter. If the UPC determines there has been infringement, subsequent proceedings would be required to determine damages. All timelines remain subject to potential rights of appeal and other customary proceedings in European patent litigation. About Enanta Pharmaceuticals, Inc. Enanta is using its robust, chemistry-driven approach and drug discovery capabilities to become a leader in the discovery and development of small molecule drugs with an emphasis on indications in virology and immunology. Enanta's clinical programs are currently focused on respiratory syncytial virus (RSV) and its earlier-stage immunology pipeline aims to develop treatments for inflammatory diseases by targeting key drivers of the type 2 immune response, including KIT and STAT6 inhibition. Glecaprevir, a protease inhibitor discovered by Enanta, is part of one of the leading treatment regimens for curing hepatitis C virus (HCV) infection and is sold by AbbVie in numerous countries under the tradenames MAVYRET ® (U.S.) and MAVIRET ® (ex-U.S.) (glecaprevir/pibrentasvir). A portion of Enanta's royalties from HCV products developed under its collaboration with AbbVie contribute ongoing funding to Enanta's operations. Please visit for more information. Forward Looking Statements Disclaimer This press release contains forward-looking statements, including statements with respect to Enanta's filing in the UPC of a suit against Pfizer Inc. and certain of its subsidiaries seeking a determination of liability for use and infringement of Enanta's patent and Enanta's expectations with respect to any further action with respect to such proceedings. Statements that are not historical facts are based on management's current expectations, estimates, forecasts and projections about Enanta's business and the industry in which it operates and management's beliefs and assumptions. The statements contained in this release are not guarantees of future performance and involve certain risks, uncertainties and assumptions, which are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed in such forward-looking statements. Important factors and risks that may affect actual results include: Enanta is competing to develop intellectual property in areas of small-molecule drug development that are highly competitive; issued patents, including those covering one or more of its product candidates, could be found invalid or unenforceable if challenged in court and could be costly to defend and be a distraction for Enanta's senior management and scientific personnel; intellectual property litigation may lead to unfavorable publicity that harms Enanta's reputation and causes the market price of its common stock to decline; and other risk factors described or referred to in 'Risk Factors' in Enanta's Form 10-K for the fiscal year ended September 30, 2024 and other periodic reports filed more recently with the Securities and Exchange Commission. Enanta cautions investors not to place undue reliance on the forward-looking statements contained in this release. These statements speak only as of the date of this release, and Enanta undertakes no obligation to update or revise these statements, except as may be required by law.
NBC News
26 minutes ago
- NBC News
A hurdle in Ukraine peace talks planning and heat wave to hit the Southwest: Morning Rundown
Some doubts and one big question have emerged in Donald Trump's push for Ukraine peace talks. A heat wave is set to grip the Southwest, while the East Coast braces for potential effects from Hurricane Erin. And after the NBA got rid of microbets, will other pro sports do the same? Here's what to know today. Trump's plan for Ukraine peace talks faces a major challenge A White House meeting this week between President Donald Trump, Ukrainian President Volodymyr Zelenskyy and several European leaders marked a rare display of trans-Atlantic unity and a chance for Trump to show his authority. And now, Trump is pushing for another spectacle: a meeting between Zelenskyy and Russian President Vladimir Putin. This is Morning Rundown, a weekday newsletter to start your day. Sign up here to get it in your inbox. Trump doubled down on the push yesterday, saying on Fox News that 'Putin is going to be good' to set up a meeting with Zelenskyy. Finnish President Alexander Stubb — who bonded with Trump over a mutual love of golf and has emerged as a pivotal figure in efforts to end the war — said he hoped for something to happen 'within the next two weeks.' But Russian Foreign Minister Sergey Lavrov was more cautious, warning that a summit would have to be 'step by step, gradually' and go 'through all the necessary steps.' The White House is actively looking to secure a meeting location and date, a senior administration official told NBC News. Hungarian capital Budapest and Geneva in Switzerland have been among the sites discussed, the official said. The site of the meeting is complicated as Putin faces an arrest warrant from the International Criminal Court that obligates the 125 countries that are party to the court to arrest the Russian leader and transfer him to The Hague for States and NATO military officials are set to meet to discuss security guarantees for Ukraine. Trump made clear Tuesday that this would not include U.S. 'boots on the ground' but could see the U.S. provide air support as part of such an arrangement. The Justice Department is investigating whether Washington, D.C., police manipulated data to make crime rates appear lower, law enforcement officials said. Trump has ordered his attorneys to conduct a review of Smithsonian museums, accusing the institutions of focusing too much 'on how bad slavery was.' Extreme heat in the Southwest, and rip currents on the East Coast An estimated 80 million people will be under extreme heat warnings and advisories across the Southwest as federal forecasters predict a swirling system of warm air will toast the region through the weekend. Warnings begin today in parts of Southern California, where Gov. Gavin Newsom is moving more firefighting resources. Warnings will also be in effect in Las Vegas, Phoenix and Tucson, Arizona, and temperatures in the 90s are expected as far north as Seattle. Here's what else to know about the heat wave. Meanwhile on the East Coast, Hurricane Erin still packs a powerful punch even though it weakened to a Category 2 yesterday morning. Dangerous rip currents were already occurring on some East Coast beaches, with no-swimming advisories in effect along coastal towns in North Carolina, Delaware and New Jersey. Erin was forecast to pass near the Bahamas last night before moving north and northeast to the U.S. East Coast today and Thursday. Here's what else to know about Hurricane Erin. Israel approves plan for Gaza City takeover, call-up of reservists Israel has approved a plan for the takeover of Gaza City that includes calling up 60,000 reservists for its expanded military operation in the besieged Palestinian enclave. The U.S. ally appeared to be pushing ahead with a new phase of its war despite international opposition — and in the face of a renewed push for a ceasefire. Defense Minister Israel Katz has authorized the plans for the major new operation, a spokesperson for the ministry confirmed to NBC News on Wednesday. It will also see an additional 20,000 reservists have their service extended, the Israeli military said. Doctors say medical misinformation has gotten worse A new survey of doctors shows medical falsehoods have grown not only online, but also within the medical exam rooms where doctors and patients interact. According to the survey of 1,002 physicians by the nonprofit research group Physicians Foundation: → 61% of doctors said they encountered patients influenced by misinformation or disinformation a moderate amount or a great deal of the time in the past year; and → 86% of physicians said the incidence of such falsehoods among patients has increased over the past five years, with 50% saying it has increased significantly The results show the difficult position medical professionals are in, said Dr. Seema Yasmin, a clinical assistant professor of medicine at Stanford University who was not involved in the study. But further research should look at how many physicians admit to having fallen for false information themselves, she said. Read All About It Raw frozen shrimp products sold at Walmart stores in 13 states may have been contaminated with radioactive material, the FDA warned. Arkansas officials' report about a man known as the 'Devil in the Ozarks' revealed how he planned his jail escape and evaded authorities for several days. A federal appeals court reversed the dismissal of a lawsuit that comedians Eric André and Clayton English filed in 2022. The pair had alleged they were stopped for racially motivated searches at Hartsfield-Jackson Atlanta International Airport. Astronomers have discovered a moon orbiting Uranus that's so small a person could walk it in two hours. Staff Pick: Could the NBA influence other sports to get rid of microbets? These days, it's not unusual to see a headline about a professional athlete ensnared in an investigation into sports gambling. What these stories often have in common is a certain type of bet, called a 'prop bet' or 'microbet,' that pro sports leagues suggest are easily manipulated by individual players. After one gambling scandal left a player permanently banned from the NBA, the league restricted how many prop bets are offered. I wanted to find out how the league persuaded its gambling partners to take down such bets and see whether it could be a precedent followed by other leagues, such as Major League Baseball, as it deals with its own sports-betting investigation. At stake is a delicate balance and potentially billions of dollars. — Andrew Greif NBC Select: Online Shopping, Simplified Talking Shop is an NBC Select series where the team talks to interesting people about their most interesting buys. We recently spoke with Tower 28 Founder and CEO Amy Liu about her favorite straw hat, water bottle, fragrance-free body wash and much more. Plus, we gathered over 30 new and notable product releases from brands like Hoka, DJI and more. here.
